Guest guest Posted October 1, 2003 Report Share Posted October 1, 2003 -----Original Message----- From: IMSSF Auto-Immune Listserv [mailto:AUTO-IMMUNE@...]On Behalf Of Automatic digest processor Sent: October 1, 2003 12:07 AM Recipients of AUTO-IMMUNE digests Subject: AUTO-IMMUNE Digest - 27 Sep 2003 to 30 Sep 2003 (#2003-99) There are 3 messages totalling 261 lines in this issue. Topics of the day: 1. Long-Term Cost Effectiveness of Interferon-Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis 2. High-Dose MS Drug Safe in Phase III Trial 3. Research News - The World of Multiple Sclerosis ---------------------------------------------------------------------- Date: Tue, 30 Sep 2003 16:30:04 -0400 From: Irwin Mortman <irwin@...> Subject: Long-Term Cost Effectiveness of Interferon-Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis Long-Term Cost Effectiveness of Interferon-Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis This analysis indicated that IFN beta-1a 44?g subcutaneously 3 times weekly is cost effective in RRMS and that treatment becomes increasingly cost effective over time. Clin Drug Invest 23(9) 2003 <http://mp.medscape.com/cgi-bin1/DM/y/hdkI0ECm7C0D2G0Fhsc0Ap> Registration required, but registration is at no cost. -- Date: Tue, 30 Sep 2003 22:08:57 -0400 From: Irwin Mortman <irwin@...> Subject: Research News - The World of Multiple Sclerosis Posting of the following article has been approved by The World of Multiple Sclerosis http://www.ifmss.org.uk/default.htm WORLD OF MS UPDATE SERVICE, 30 September 2003 Research News ==================== Directional diffusion in relapsing-remitting multiple sclerosis: A possible in vivo signature of Wallerian degeneration. -------------------- Direction specific changes in diffusion may be a marker of Wallerian degeneration in MS according to the authors of this study. http://www.msif.org/go.rm?id=10665 ApoE genotype and an apoE-mimetic peptide modify the systemic and CNS inflammatory response. -------------------- This study looks at the role of isoforms of apolipoprotein E in mediating inflammatory response in mice expressing human apoE3 and apoE4 genes. Animals with the E4 allelle were found to produce greater elevations of inflammatory cytokines and administration of an apoE mimetic peptide was found to suppress inflammation. http://www.msif.org/go.rm?id=10666 Genetic Analysis of the Influence of Neuroantigen-Complete Freund's Adjuvant Emulsion Structures on the Sexual Dimorphism and Susceptibility to Experimental Allergic Encephalomyelitis. -------------------- Physical properties of the antigen emulsion used to induce the animal model of MS are found to alter susceptibility. This variation in susceptibility to the different preparations appears to have a genetic base. http://www.msif.org/go.rm?id=10667 The Protective Effect of 17beta-Estradiol on Experimental Autoimmune Encephalomyelitis Is Mediated through Estrogen Receptor-alpha. -------------------- The ability of estrogen to inhibit the animal model of MS appears to depend on estrogen alpha rather than estrogen beta receptors according to the authors of this study using mice with disrupted alpha and beta receptor genes. http://www.msif.org/go.rm?id=10668 CD8(+) phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destruction. -------------------- A study looking at the expression of CD8 positive cells, by location, in demyelinating and non-demyelinating animal models of MS. http://www.msif.org/go.rm?id=10669 Astrocyte characterization in the multiple sclerosis glial scar. -------------------- This study finds a distinctive antigen profile of astrocytes in chronic MS lesions. http://www.msif.org/go.rm?id=10670 Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis. -------------------- A study using magenetic resonance spectroscopy finds that attentional deficit in early relapsing remitting MS appears to relate to damage in the right locus coeruleus. http://www.msif.org/go.rm?id=10671 Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. -------------------- A study looking at all 23 matrix metalloproteinase family members finds MMP-2 and MMP-14 (two of the monocyte expressed MMPs) specifically raised in MS. http://www.msif.org/go.rm?id=10672 Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of multiple sclerosis. -------------------- The performance of patients affected by clinically isolated syndromes and control subjects on a cognitive test was compared. Performance on the test itself did not differ but increased brain activation in several brain regions was seen in patients. These changes might be part of a compensatory mechanism. http://www.msif.org/go.rm?id=10673 HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis. -------------------- A study looking at the effects of HLA status on disease severity in MS as assessed clinically and in terms of degree of MRI abnormlity. T1 and T2 lesion loads were found to have different HLA associations. http://www.msif.org/go.rm?id=10674 Apolipoprotein E genotype does not influence the progression of multiple sclerosis. -------------------- This study, of 498 individuals affected by MS, does not find an association between apolipoprotein polymorphisms and rate of clinical progression. http://www.msif.org/go.rm?id=10675 Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1a. -------------------- This study, looking at matrix metalloproteinase 9 levels in patients affected by primary progressive MS taking part in a trial of interferon beta 1a, finds that mean absolute levels of MMP-9 correlated with an increase in T2 lesion load. Associations with atrophy measures were also found but only the association with T2 load was sustained throughout the study period. http://www.msif.org/go.rm?id=10676 Fatigue in MS is related to sympathetic vasomotor dysfunction. -------------------- Aspects of the autonomic response (specifically a pattern resembling a hypoadrenergic orthostatic response) are found to be associated with fatigue in patients affected by MS by the authors of this study. http://www.msif.org/go.rm?id=10677 -- =========================================== End of AUTO-IMMUNE Digest - 27 Sep 2003 to 30 Sep 2003 (#2003-99) ***************************************************************** Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.